Drug Discovery| Metabolism | Pharmaceutical Development| Toxicology| Analysis

Manufacturing| Information| Regulatory Issues| Databases| Services| BioStocks

DRUG DISCOVERY


Email me!

 
Multiplex Assays
  • 1. Microarrays
  • High-Throughput Microchips
    Affymetrix¡¯s GeneChip
    Agendia¡¯s MammaPrint
    Extension Arrays
    Asper Biotech¡¯s APEX Technology
    Electronic Platforms
    Osmetech¡¯s eSensor Detection Technology
    PCR-Based Assays
    Applied Biosystems¡¯ TaqMan Probes
    Epigenomics¡¯ MethyLight
    Genomic Health¡¯s Oncotype DX
    OncoMethylome Sciences¡¯ Methylation-Specific PCR (MSP)
    Gene Express¡¯ StaRT-PCR

  • 2. Protein Microarrays

    • Antibody Arrays
      Biosite¡¯s Protein Arrays
      Biosite¡¯s Triage Panel Products
      Biacore¡¯s Life Sciences Protein Microarray
      BD Biosciences¡¯ Cytometric Bead Array
      Zeptosens¡¯ ZeptoMark Capture Microarray and ZeptoMark CeLyA Reverse Microarray
      High Throughput Genomics¡¯ ArrayPlate qNPA
      Pierce¡¯s Protein Array Kits
      PamGene¡¯s PamChip Microarray
      Microsphere or Bead-Based Technologies
      Luminex¡¯s xMAP Technology
      Molecular Probes¡¯ Qdot Nanocrystals
      Oxonica¡¯s Nanoplex Technology
      Pronostics¡¯ UltraPlex Barcodes Molecules
      Illumina¡¯s BeadXpress Reader and VeraCode Technology
      BioArray Solutions¡¯ BeadChip
      Randox¡¯s Evidence
      Xceed Molecular¡¯s Flow-Thru Chip and TipChip Technology
      Decision Biomarkers¡¯ Avantra Q400 Biomarker Workstation
      Meso Scale Discovery¡¯s Platform
      Bio-Rad¡¯s BioPlex

  • 3. Imaging Technologies
    • Stratos Biosystems¡¯ EC-Affinity Biochips
      Blueshift Biotechnologies¡¯ IsoCyte

  • 4. Miscellaneous Assay Technologies
    • Monogram Biosciences¡¯ eTag

    5. APPLIED MULTIPLEX ASSAY

    • Translating Discoveries Made in Animal Models to Humans
      Discoveries in Pharmacogenomics
      Assay Technologies in Disease Diagnosis
      Translational Research to Help in Disease Prevention
      More ¡°System¡±-Oriented Assay Technologies
      The Growth of Personalized Medicine Companies

    6 FDA PERSPECTIVE ON MULTIPLEX ASSAY TECHNOLOGIES

    • Critical Path Initiative (CPI)
      Oncology Biomarker Qualification Initiative (OBQI)
      Predictive Safety Testing Consortium (PSTC)

 

Email: infor@yalepharma.com

1996-2010 Yale Pharmaceutical Research Institute. All Rights Reserved.